Latest News & Updates
Breaking News
6 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Abbott Secures CE Mark for Libre Duo Dual Glucose-Ketone Sensor Targeting DKA Detection
Abbott gains CE Mark for Libre Duo, the first dual glucose-ketone continuous sensor, with a phased European launch planned for late 2026.
Pharma Now Editorial Team
TIRF Manufacturers Discontinue All Products as REMS Obligations Remain Fully Active
TIRF medicines discontinued Sept 30, 2024, but REMS obligations persist for all NDA/ANDA holders until applications are formally withdrawn.
Pharma Now Editorial Team
FDA Requests Removal of Statin Pregnancy Contraindication, Triggering Labeling Updates Across Entire Drug Class
FDA requests removal of the class-wide statin pregnancy contraindication, requiring labeling revisions across all branded and generic statin products.
Pharma Now Editorial Team
Sun Pharma Achieves 50% Response Rate in Phase II Trial for Locally Advanced Cutaneous Squamous Cell Carcinoma
Sun Pharma's Phase II laCSCC trial hits 50% response rate, signalling accelerated regulatory filing timelines and biologics manufacturing scale-up demands.
Pharma Now Editorial Team
